First Trust Nasdaq Pharmaceuticals ETF
FTXH
6 hedge funds and large institutions have $524K invested in First Trust Nasdaq Pharmaceuticals ETF in 2017 Q2 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
50% more funds holding
Funds holding: 4 → 6 (+2)
6.34% less ownership
Funds ownership: 31.64% → 25.3% (-6.3%)
17% less capital invested
Capital invested by funds: $628K → $524K (-$104K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$457K |
| 2 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$9.62K |
| 3 |
RAM
Riggs Asset Management
Dallas,
Pennsylvania
|
+$3.06K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$587K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1.33K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $469K | +$457K | +22,677 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $26K | -$1.33K | -66 | -5% |
|
3
Royal Bank of Canada
Toronto,
Ontario, Canada
| $12K | – | – | – |
|
|
LTFS
4
Ladenburg Thalmann Financial Services
Miami,
Florida
| $10K | +$9.62K | +478 | New |
|
|
IA
5
IFP Advisors
Tampa,
Florida
| $4K | – | – | – |
|
|
RAM
6
Riggs Asset Management
Dallas,
Pennsylvania
| $3K | +$3.06K | +152 | New |
|
|
VKH
7
Virtu KCG Holdings
New York
| – | -$587K | -29,579 | Closed |
|
FTXH Hedge Fund Activity: Q2 2017 in Review
6 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in First Trust Nasdaq Pharmaceuticals ETF (FTXH) for Q2 2017, worth a combined $524K — down 17% from $628K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new FTXH positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $457K. The largest seller was Virtu KCG Holdings, exiting entirely with an estimated $587K sold.
- 6 institutional investors held First Trust Nasdaq Pharmaceuticals ETF (FTXH) as of Q2 2017, up from 4 in Q1 2017.
- Funds reported $524K of First Trust Nasdaq Pharmaceuticals ETF stock for Q2 2017, down 17% quarter-over-quarter.
- 3 funds opened new First Trust Nasdaq Pharmaceuticals ETF positions in Q2 2017 and 1 closed out, a net change of +2 holders.
- The largest First Trust Nasdaq Pharmaceuticals ETF buyer in Q2 2017 was Susquehanna International Group, an estimated $457K added.
- The largest First Trust Nasdaq Pharmaceuticals ETF seller in Q2 2017 was Virtu KCG Holdings, an estimated $587K sold.
Based on aggregated 13F filings for Q2 2017.